Pot Battles Cancer On Yet Another Front
Puff, puff, cure colorectal cancer, pass….This might one day be the chant of doctors everywhere, depending on the accuracy of a recent study at M.D. Anderson.
Researchers there have announced that a “cannabinoid receptor” in cells might be a key tumor-fighting tool in patients with colorectal cancer.
In a press release, MD Anderson’s executive vice president Raymond Dubois stated: “Potential application of cannabinoids as anti-tumor drugs is an exciting prospect, because cannabinoid agonists are being evaluated now to treat the side effects of chemotherapy and radiation therapy.”
Roughly translated, this means that preclinical tests show that sparking a bowl seems to spark the tumor-fighting capabilities of a certain cellular receptor – and it’s a lot more fun than chemo.
Rice Owls Mens Basketball vs. Charlotte Mens Basketball
TicketsSat., Jan. 28, 7:00pm
Gridiron Glory: The Best of Pro Football HOF -- 10AM-3PM
TicketsMon., Jan. 30, 10:00am
Gridiron Glory: The Best of Pro Football HOF -- 3PM-8PM
TicketsMon., Jan. 30, 3:00pm
Super Bowl Opening Night Fueled By Gatorade
TicketsMon., Jan. 30, 7:00pm
For those not in the know, the press release states that “external cannabinoids include manmade versions and those present in plants, most famously the active ingredient in marijuana (THC).” (We like that term, “most famously”).
Although it’s not mentioned in the press release, this latest breakthrough appears to advance decades’ worth of research from such giants in the field as Drs. Spicoli, Dogg, Cheech, Slater, and Chong.
-- Craig Malisow
Get the ICYMI: Today's Top Stories Newsletter Our daily newsletter delivers quick clicks to keep you in the know
Catch up on the day's news and stay informed with our daily digest of the most popular news, music, food and arts stories in Houston, delivered to your inbox Monday through Friday.